Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vlassara

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|February 25, 1984
Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitusM Brownlee, H Vlassara, A Cerami, et al.
The Journal of Experimental Medicine|November 1, 1991
Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reactionB Li, P K Sehajpal, A Khanna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1995
Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbitsW Palinski, T Koschinsky, S W Butler, et al.
Science (New York, N.Y.)|October 23, 1992
Hemoglobin-AGE: a circulating marker of advanced glycosylationZ Makita, H Vlassara, E Rayfield, et al.
The Journal of Experimental Medicine|September 1, 1991
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteinsZ Yang, Z Makita, Y Horii, et al.
The American Journal of Pathology|February 1, 1997
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused ratsA W Stitt, Y M Li, T A Gardiner, et al.
Molecular Medicine (Cambridge, Mass.)|September 1, 1995
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexH Vlassara, Y M Li, F Imani, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidineY M Li, M Steffes, T Donnelly, et al.
The Journal of Experimental Medicine|December 1, 1993
Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodelingF Imani, Y Horii, M Suthanthiran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Advanced glycation end products up-regulate gene expression found in diabetic glomerular diseaseC W Yang, H Vlassara, E P Peten, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|February 25, 1984
Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitusM Brownlee, H Vlassara, A Cerami, et al.
The Journal of Experimental Medicine|November 1, 1991
Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reactionB Li, P K Sehajpal, A Khanna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1995
Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbitsW Palinski, T Koschinsky, S W Butler, et al.
Science (New York, N.Y.)|October 23, 1992
Hemoglobin-AGE: a circulating marker of advanced glycosylationZ Makita, H Vlassara, E Rayfield, et al.
The Journal of Experimental Medicine|September 1, 1991
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteinsZ Yang, Z Makita, Y Horii, et al.
The American Journal of Pathology|February 1, 1997
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused ratsA W Stitt, Y M Li, T A Gardiner, et al.
Molecular Medicine (Cambridge, Mass.)|September 1, 1995
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexH Vlassara, Y M Li, F Imani, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidineY M Li, M Steffes, T Donnelly, et al.
The Journal of Experimental Medicine|December 1, 1993
Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodelingF Imani, Y Horii, M Suthanthiran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Advanced glycation end products up-regulate gene expression found in diabetic glomerular diseaseC W Yang, H Vlassara, E P Peten, et al.
Pageof 12